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Abstract 
Oncogenic activation of the ETS Related Gene (ERG) in humans was originally identified in 
subsets  of  Ewing  sarcomas,  myeloid  leukemias  and,  recently,  in  the  majority  of  prostate 
cancers. Expression of human ERG protein and consequently its functions in normal and 
d i s e a s e   s t a t e s   n e e d s   t o   b e   b e t t e r   u n d e r s t o o d   i n   l i g h t   o f   i t s   s u g g e s t e d   r o l e   i n   c e l l   d i f f e r e n t i a t i o n  
and proliferation.  Here, we  analyzed temporal and spatial expression of the Erg (mouse 
protein) by immunohistochemical analysis during mouse embryonic and adult organogenesis 
using a highly specific ERG monoclonal antibody (ERG MAb). This study establishes wide-
spread immunolocalization of Erg protein in endothelial cells and restricted expression in 
precartilage and hematopoietic tissues. Intriguingly, Erg is not expressed in any epithelial tissue 
including prostate epithelium, or in infiltrating lymphocytes that are occasionally seen in the 
prostate environment, a common site of tumors with ERG rearrangements and unscheduled 
ERG expression. These findings will further aid in investigations of Erg functions in normal and 
disease conditions. 
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Introduction 
Chromosomal translocations leading to gene fu-
sions have been well characterized in variety of ma-
lignancies [1]. G e n e   f u s i o n s   o f t e n   r e s u l t   i n   c h i m e r i c  
proteins  with  aberrant  functions  and/or  ectopic  ex-
pression.  Frequent  elevated  expression  of  the  ETS 
related genes (ERG) due to chromosomal rearrange-
ments  resulting  into  the  fusion  between  androgen 
regulated  promoters  (predominatlyTMPRSS2)  and 
protein coding sequence of ETS transcription factors 
has  been  established  in  prostate  cancer  [2,  3].  ETS 
(Erythroblast Transformation Specific family of tran-
s c r i p t i o n   f a c t o r s )   g e n e s   a r e   a   l a r g e   f a m i l y   w i t h   a t   l e a s t  
thirty members that function as transcription factors 
[4]. All ETS transcription factors share a highly con-
served DNA binding domain, the ETS domain [5] and 
at least Ets1, Erg,  Fli1 and Etv2 are expressed in em-
bryonic endothelial cells of mouse [6, 7]. ERG is well 
conserved in evolution and its expression and poten-Journal of Cancer 2010, 1 
 
http://www.jcancer.org 
198 
tial functions have been studied in xenopus, zebrafish, 
mouse  and  humans  [8-12].   T h e   r e s u l t s   f r o m   t h e s e  
studies suggest an emerging role for ERG in the tran-
scriptional  regulation  of  endothelial  specific  genes 
[13-16] and in definitive hematopoiesis [17, 18].  Both 
hematopoietic and endothelial cells are of mesoder-
mal origin and are derived from the hemangioblast, a 
common  precursor,  suggesting  a  shared  develop-
mental pathway [19].   K n o c k -down of Erg is associated 
w i t h   a   s i g n i f i c a n t   r e d u c t i o n   i n   t h e   f o r m a t i o n   o f   v a s-
cular  structures  and  the  number  of  endothelial  cells 
[20] and  with  apoptosis  [21]. These studies indicate 
that Erg may have important implications in vascular 
development during mouse embryogenesis. Although 
Erg does not appear to be required for hematopoiesis 
during  embryonic  stem  cell  differentiation,  it  may 
play  a  role  in  endothelial  cell  differentiation  [20]. 
Hematopoietic  stem  cells  give  rise  to  both  T-  and 
B-lymphocytes  in  embryogenesis  and  throughout 
adult  li f e .   A l t h o u g h   m a t u r e   T -lymphocytes  do  not 
express Erg, expression is detected transiently during 
T-lineage  specification  and  is  silenced  after  their 
commitment  [22]. During  B-cell development in the 
mouse,  Erg  expression  was  detected  in  early  pre-B 
cells, pre-B   a n d   i n   m a t u r e   B   c e l l s   [23]. In developing 
mouse, Erg mRNA is expressed in mesodermal tissues 
such as endothelial cells, mesenchymal condensations 
during precartilaginous depositions, and in urogenital 
regions [11].   A l l   o f   t h e   e x p r e s s i o n   s t u d i e s   w e r e   c a r r i e d  
o u t   b y   u s i n g   R T -PCR or in situ hybridization. How-
e v e r ,   t h e   p r o t e i n   e x p r e s s i o n   a n d   i t s   c e l l u l a r   d i s t r i b u-
tions  could  not  be  pe r f o r m e d   d u e   t o   a   l a c k   o f   a n  
Erg-specific antibody.  
T h e   g o a l   o f   t h i s   s t u d y   w a s   t o   e s t a b l i s h   t h e   e x-
pression  pattern  of  Erg  protein  in  developing  and 
adult  mouse  tissues  by using an ERG-specific  anti-
b o d y .   T h e s e   d a t a   w o u l d   s e r v e   a s   a   b a s i s   t o   u n d e r s t a n d  
the  function  of  Erg  during  normal  development  in 
many organs and pathological conditions, such as its 
cancer-specific expression in prostatic adenocarcino-
ma. Although several antibodies for detecting human 
E R G   p r o t e i n   a n d   m o u s e   E r g   p r o t e i n   h a v e   b e e n   d e-
scribed, due to high degree of homology among ETS 
family members, in particular its closest homologue 
Fli-1,   a n t i b o d y   c r o s s   r e a c t i v i t y   h a s   b e c o m e   a   m a j o r  
c o n c e r n   i n   d e t e c t i o n   o f   t h e   E R G   p r o t e i n .  Recently, we 
have  generated  and  characterized  an  ERG-specific 
mouse monoclonal antibody that showed high speci-
f i c i t y   t o w a r d s   E R G   p r o t e i n   t h a t   d o e s   n o t   c r o s s   r e a c t  
with FLI-1  protein  [24]. I n   t h e   p r e s e n t   s t u d y ,   w e   e x-
amined  the  detailed  expression  of  the  Erg  protein 
during prenatal and adult mouse organogenesis.  
Results and discussion 
Evaluation of ERG Monoclonal Antibodies for 
the Specificity of ERG Protein Detection: We eva-
luated the specificity of three recently available ERG 
monoclonal antibodies including the ERG MAb that 
we recently reported [24]. As noted  previously,  the 
E R G   M A b   d e t e c t e d   E R G   p r o t e i n   p r o d u c t s   i n   M O L T 4 ,  
K G 1 ,   C O L O   3 2 0   a n d   V C a P   t u m o r   c e l l   l i n e s ,   w h e r e a s  
LNCaP, MCF7 and Jurkat cell lines were negative for 
ERG. T h e   E R G   M A b   d i d   n o t   s h o w   c r o s s   r e a c t i v i t y   t o  
FLI-1 in LNCaP cells infected with a FLI-1 adenovirus 
expression vector (Fig 1A). Under similar assay con-
ditions,  rabbit  monoclonal  antibodies  to  ERG  (EPR 
3 8 6 4   a n d   E P R   3 8 6 3 )   o b t a i n e d   f r o m   E p i t o m i c s   ( B u r-
lingame, CA) detected FLI-1 in LNCaP cells infected 
with  a  FLI-1  adenovirus  expression  vector  (Fig  1B, 
1C). In addition, a rabbit monoclonal ERG antibody 
EPR 3864 detected a protein in Jurkat cell line (acute T 
cell leukemia) that was not recognized by either the 
r a b b i t   m o n o c l o n a l   a n t i b o d y   E P R   3 8 6 3   o r   o u r   E R G  
M A b   s u g g e s t i n g   p o t e n t i a l   c r o s s   r e activity  to  other 
ETS related proteins by EPR 3864. Interestingly, other 
monoclonal ERG antibody EPR 3863 recognized FLI-1 
i n   L N C a P   c e l l s   i n f e c t e d   w i t h   a   F L I -1   a d e n o v i r u s   e x-
pression vector. Taken together, the results obtained 
from immunoblot analyses suggest that the ERG MAb 
w e   d e v e l o p e d   i s   h i g h l y   s p e c i f i c   f o r   E R G   p r o t e i n   d e-
tection and was further assessed in other immunoas-
says. 
To determine the efficiency of ERG  MAb anti-
b o d y   i n   a   p r o s t a t e   t u m o r   m o d e l ,   w e   a n a l y z e d   E R G  
expression in ERG-positive VCaP and ERG-negative 
L N C a P   p r o s t a t e   c a n c e r   c e l l   t u m o r   x e n o g r a f t s   i n   S C I D  
mice. The ERG  MAb antibody detected ERG protein 
in VCaP xenografts, staining primarily the nuclei with 
some  cytoplasmic  reactivity  (Fig  2A).  As  expected, 
ERG negative LNCaP xenografts d i d   n o t   s how  ERG 
expression.  The  endothelial  cells  lining  the  blood 
vessels and capillaries showed positive reactivity to 
ERG MAb in tumors as well as normal adjacent tissue 
( F i g   2 B ) .   F u r t h e r ,   w e   e v a l u a t e d   t h e   E R G   M A b   f o r   t h e  
detection  of  ERG  protein  the  prostates  of 
ERG-transgenic mice [25]. Transgenic ERG expression 
was detected in the prostate luminal epithelial cells of 
ERG-transgenic  mice  (Fig  2C). In addition, endogen-
ous Erg protein was detected only in the endothelial 
cells of blood vessels and capillaries (Fig  2D).  Infil-
trating lymphocytes did not show immune-reactivity 
t o   E R G   M A b   ( F i g   2   E ,   G ) .   C o n s i s t e n t   w i t h   a   r e c e n t  
report  [26],  rabbit  monoclonal  antibodies  EPR  3864 
showed a strong staining of lymphocytic infiltration 
in prostate gland (Fig 2F, H). Interestingly, both the 
rabbit  monoclonal  ERG  antibodies  (EPR  3864,  EPR Journal of Cancer 2010, 1 
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3863) and FLI-1  antibodies  have  shown  reactivity to 
infiltrating lymphocytes (Fig 2I, J). It is interesting to 
note  that  ERG  is  turned  on  at  transition  stage  (be-
tween precursor and pro-T   s t a g e   1 )   o f   T -cell differen-
t i a t i o n   a n d   d o e s   n o t   p e r s i s t   s t a b l y   t o   d e f i n e   T -cell 
identity, and is shut off after T cell lineage commit-
ment [22, 27, 28].   I n   t h i s   s t u d y ,   w e   h a v e   n o t   c h a r a c t e-
rized  the  trans i e n t   e x p r e s s i o n   o f   E r g   d u r i n g   T -cell 
development and differentiation.  
To study the utility of the E R G   M A b  to detect the 
expression  of  ERG  in  cells  using  flow  cytometry, 
s e v e n   h u m a n   c a n c e r   c e l l   l i n e s ,   V C a P   a n d   L N C a P  
(prostate  cancer),  T2  and  Jurkat  (T  lymphoblastoid 
cells), KG-1   a n d   K G -1a (myeloblastic) were analyzed. 
All  cell  lines  were  permeabilized  by  standard  cell 
intracellular  staining  methods  by  using  detergent 
followed by incubation with the ERG MAb and  sec-
ondary  fluorochrome-conjugated  antibodies.  As 
shown  in  Fig    3 C   a n d   D ,   e x p r e s s i o n   o f   E R G   w a s  
clearly  detectable  in  the  TMPRSS2-ERG  fu-
sion-harboring  VCaP   c e l l s   a n d   w a s   n o t   o bserved in 
the TMPRSS2-ERG negative LNCaP cells (Fig 3A, 3B). 
I n   t h e   c a s e   o f   t h e   h e m atopoietic/lymphoblastoid 
canc e r   c e l l s   o f   t h e   T   l y mphocyte lineage, ERG expres-
s i o n   w a s   d e t e c t e d   n e i t h e r   i n   T 2   ( F i g   3 I ,   3 J )   n o r   i n   J u r-
kat cells (Fig 3K, 3L). With the hematopoietic cell lines 
o f   m y e l o i d   l i n e a g e ,   K G -1   a n d   K G -1 a ,   t h e   e x p r e ss i o n   o f  
ERG was clearly detectable in both cell lines (Fig 3E, 
3 F   a n d   F i g   3 G ,   3 H ) .   I n t e r e s t i n g l y ,   t h e   K G -1a  cells, 
w h i c h   a r e   c o n s i d e r e d   t o   b e   l e s s   m a t u r e   o r   d i f f eren-
tiated   t h a n   t h e   K G -1  cells,  expressed  much  higher 
a m o u n t s   o f   t h e   E R G   p r o t e i n .   T a k e n   t o g e t h e r ,   t h e   c o n-
sistent results of Western blot, IHC and FACS assays 
established the specificity of the ERG MAb in detect-
ing ERG protein in different assay platforms and bio-
logical specimen contexts. 
 
 
 
 
 
Figure 1: Expression of human ERG protein in cancer–derived cell lines: ERG protein expression was analyzed by using 
total cell lysates from acute T cell leukemia (Jurkat), breast cancer cell line (MCF7) acute myelogenous leukemia cell line 
(KG1), colon carcinoma cells (COLO320), acute lymphoblastic leukemia (MOLT-4), ERG expressing prostate cancer cell 
line (VCaP) treated with non target siRNA (VCaP-NT), prostate cancer cell line (VCaP) treated with ERG specific siRNA 
(VCaP ERG-si-1), prostate cancer cell line LNCaP, prostate cancer cell line LNCaP transduced with adenoviral FLI-1 ex-
pression vector. Extracted proteins were processed for immunoblot assay by using (A) mouse monoclonal ERG antibodies 
ERG MAb, (B) rabbit monoclonal anti-ERG antibodies Epitomics EPR 3864 Cat.No 2805-1, (C). Rabbit monoclonal anti-ERG 
antibodies Epitomics EPR 3863 Cat.No 2849-1. Note the lack of immunoreactivity to the protein extracts from Jurkat, 
LNCaP and LNCaP transdu c e d   w i t h   a d e n o v i r a l   F l i -1 expression vector with ERG MAb in panel A, and reactivity with other 
antibodies in panel B and C. Journal of Cancer 2010, 1 
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Figure  2:  Expression  of 
ERG protein in FFPE tissue: 
ERG protein expression in 
(A)  VCaP  and  (B)  LNCaP 
xenograft tumors obtained 
from  SCID  mice.  Strong 
expression of ERG in VCaP 
cells  (black  arrow).  ERG 
staining is seen only in the 
endothelial cells (arrow) of 
LNCaP tumors but not in 
the epithelial cells. Expres-
s i o n   o f   E R G   p r o t e i n   i s   d e-
tectable  in  the 
ARR2PBΔN-ERG  trans-
genic mouse prostates (C) 
compared  to  wild-type 
littermate control (D). In-
filtrating  lymphocytes  are 
occasionally  seen  in  the 
prostate  glands  and  show 
no reactivity to ERG MAb 
(E,  G).  However,  strong 
staining is seen in the infil-
trating  lymphocytes  with 
Epitomics EPR 3864 (F, H), 
EPR 3863 (I) and FLI1 an-
tibody (J).  
   Journal of Cancer 2010, 1 
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Figure  3. ERG expression in 
cancer  cell  lines.  Intracellular 
staining  was  carried  out  in 
permeabilized  cells  with  an 
IgG1 isotype control antibody 
( A ,   C ,   E ,   G ,   I   a n d   K )   o r   f o r   E R G  
w i t h   E R G   M A b   ( B ,   D ,   F ,   H ,   J  and 
L)  and  detected  by  using 
FITC-conjugated  secondary 
antibody  and  flow  cytometry 
analysis.  
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Erg protein expression in  prenatal mouse  de-
velopment:  D u r i n g   E 9 . 5 d ,   s t r o n g   e x p r e s s i o n   o f   E r g  
protein was detected by the ERG MAb mainly in the 
endothelial cells of blood vessels around the neural 
t u b e   ( F i g   4 A ,   4 B ) .  Additionally, expression was also 
prominent in the cells that line the amnion (Fig 4A). 
At this stage, during heart development, the ventricle 
begins trabeculation to demarcate this region from the 
primitive heart.  E x p r e s s i o n   o f   E r g   w a s   o b s e r v e d   i n  
endothelial cells that line the trabeculated regions of 
the ventricle (Fig 4C). Endothelial cells present in the 
inter-s o m i t i c   c a p i l l a r i e s   s h o w   s t r o n g   e x p r e s s i o n   o f   E r g  
(Fig 4D). Similar endothelial-specific expression was 
found in the dorsal aorta and around the neural tube 
(Fig 4E). The distribution observed with ERG  MAb 
antibody is consistent with earlier reported studies of 
Erg  mRNA  expression  [11,  20].  Similar  to  earlier 
s t a g e s   o f   d e v e l o p m e n t ,   a t   E 1 2 . 5 d ,   E r g   e x p r e s s i o n   w a s  
endothelial cell-s p e c i f i c   i n   t h e   m a j o r i t y   o f   t h e   t i s s u e s  
(Fig 5). In addition to endothelial expression, Erg ex-
pression  was  detected  in the  precartilage/  cartilage 
p r i m o r d i u m   o f   t h e   n a s a l   s e p t u m ,   n e u r a l   a r c h   a n d   r i b  
(Fig 5A, 5B, 5C). Mesenchymal condensations are re-
quired  at  this  stage  to  initiate  the  paving  cartilage 
path for  both transient and permanent cartilage. The 
transient cartilage will undergo ossification to form 
bone. Interestingly, Erg expression was observed only 
in the precartilage primordium suggesting that Erg 
m a y   h a v e   c r i t i c a l   r o l e   i n   t h e   d i f f e r e n t i a t i o n   o f   c a r t i-
lage.  Heart  development  at  this  stage  exhibited  ex-
tensive  trabeculation  of  the  ventricle  and  showed 
clear  lining  of  endothelial  cells  with  positive  Erg 
staining along the trabeculated endocardium (Fig 5B). 
L u n g s   a t   t h i s   s t a g e   w e r e   n o t   y e t   d i v i d e d   i n t o   l o b es 
and  the  stroma  with  enriched  capillaries  exhibited 
strong expression of Erg in developing lung (Fig 5D). 
Epithelial cells of segmental bronchus did not show 
Erg expression (Fig 5D). Kidney at this stage starts 
subdividing into cortical and medullary regions.  Ex-
p r e s s i o n   w a s   d e t e c t e d   o n l y   i n   t h e   b l o o d   v e s s e l s   a n d  
capillaries uniformly throughout the kidney and not 
in the kidney cortex or medulla (Fig 5E).  
 
 
 
Figure 4. Expression pattern of Erg protein during mouse embryogenesis (E9.5d): Embryonic 9.5d mouse showing the 
expression of Erg protein by immunohistochemistry with ERG MAb. (A) Coronal section of an E9.5 embryo showing a 
specific staining in blood vessels (bv) , inter-somitic vessels (is) and in the amnion (am). (B) Higher magnification of hind brain. 
E x p r e s s i o n   i s   n o t   s e e n   i n   t h e   h i n d   b r a i n   ( h b ) ,   n e u r a l   t u b e   ( n t )   a n d   o p t i c   v e s i c l e   ( o ) .   ( C ) .   H i g h e r   m a g n i f i c a t i o n   o f   v e n t r i c l e  (vt) 
region of the heart showing strong signal in the endothelial cells (ec)along the trabeculated endochordium (D) Hihger 
magnification of somites in the caudal region showing Erg expression in the inter somatic blood vessels (sv) . (E). Tail region 
of the embryo showing neural tube (nt) midline dorsal aorta (mda). Erg expression was detectable only in the endothelial 
cells of dorsal aorta. Somites (s). Journal of Cancer 2010, 1 
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F i g u r e   5 . Expression pattern of Erg protein during mouse embryogenesis: (E12.5). (A) Sagittal section of an E12.5d embryo 
s h o w i n g   a   s p e c i f i c   s t a i n i n g   i n   c a r t i l l a g e   p r i m o r d i u m   ( c p )   o f   t h e   n a s a l   s e p t u m   ( n s ) ,   a n d   t h e   m i d   s h a f t   r e g i o n   o f   t h e   r i b   ( r b ) .   ( B )  
Higher magnification of ventricle (vt) region of the heart showing strong expression in the endothelial cells (ec) along the 
trabeculated endocordium. (C) Erg protein was detectable in the precartillage condensations in the neural arch (na). (D) 
Higher magnification of developing lungs (not yet divided into lobes) show lack of expression in the epithelial cells of 
segmental bronchus (sb). Surrounding stroma with enrihed capillaires exhibit strong staining. (E). Expression is seen only in 
endothelial cells of the blood vessels and capillaries uniform throughout the kidney. 
 
E r g   e x p r e s s i o n   i n   E 1 4 . 5 d   w a s   f o u n d   m o s t l y   i n  
t h e   e n d o t h e l i a l   c e l l s   o f   v a r i e t y   o f   t i s s u e s   ( F i g   6 ) .   I n  
developing liver, about 1-2% of liver cells exhibited 
reactivity with ERG  MAb antibody  and  megakaryo-
c y t e s   d i d   n o t   s h o w   E r g   e x p r e s s i o n .   E x p r e s s i o n   i n   t h e  
cartilage  appeared  to  be  reduced significantly  com-
p a r e d   t o   E 1 2 . 5 d   i n   t h e   r i b ,   n a s a l   s e p t u m   a n d   v e r t e-
brae. We found significant differences between ERG 
MAb  and  rabbit  monoclonal  ERG  antibodies  EPR 
3864 megakaryocytic immunostaining. No significant 
changes in the Erg expression patterns were observed 
i n   t h e   l a t e r   s t a g e s   o f   m o u s e   d e v e l o p m e n t .   As  the 
overexpression of ERG in the prostate is implicated in 
t h e   o n c o g e n i c   p r o c e s s ,   w e   e x a m i n e d   t h e   n o r m a l   e x-
pression of Erg protein in developing prostate glands. 
I n   t h e   m o u s e ,   t h e   p r o s t a t i c   b u d s   f i r s t   e m e r g e   a t   t h e  
rostral  end  of  the  urogenital  sinus  at  approximately 
17.5 days of gestation and subsequently, the prostatic 
epithelial buds undergo extensive ductal outgrowth 
and  branching  morphogenesis  into  the  surrounding 
mesenchyme during the first three weeks of postnatal 
development.  Interestingly,  Erg  staining  was  ob-
served  only  in  the  mesenchymal  compartment  and 
restricted  to  capillary  endothelial  cells  (Fig  7)  sug-
gesting that Erg may not be critical in normal prostate 
development or differentiation. 
I n   l i v e r   o f   E 1 7 . 5 d   m i c e ,   t h e   e x p r e s s i o n   o f   E r g   i s  
restricted  to very  few  cells  such as  endothelial  and 
other non-parenchymal cells which later differentiate 
into Kupffer cells and hepatic stellate cells. It is  not 
clear at  this stage  which type  of  cells in addition  to 
e n d o t h e l i a l   c e l l s   e x p r e s s   E r g   p r o t e i n .  S i m i l a r   t o   E 1 4 . 5 d  
liver megakaryocytes, ERG  MAb did not show reac-
tivity with E17.5d hepatic megakaryocytes (Fig 8A). 
However,  rabbit  monoclonal  ERG  antibodies  EPR 
3864 showed a strong staining in megakaryocytes, in 
addition to endothelial and other cell types (Fig 8B). 
Expression  of  Erg  protein  in  adult  mice:  We 
e x t e n d e d   o u r   s t u d y   t o   a d u l t   m o u s e   t i s s u e s   t o   a n a l y z e  
the expression of Erg protein (Fig 9). Simil a r   t o   e m-
bryonic tissues, the expression of Erg was observed in 
t h e   e n d o t h e l i a l   c e l l s   o f   t h e   a d r e n a l   g l a n d ,   c a r t i l a g i n-
o u s   c o m p o n e n t   o f   b o n e ,   h e a r t   m u s c l e ,   k i d n e y ,   l i v e r ,  
lung, spleen urinary bladder. Erg expression was also 
evident  in  the  lymphatic  endothelial  cells  in  adult 
mouse. As expected, expression was undetectable in 
the prostate epithelium. Detailed examination of these 
tissues has revealed that the expression was mostly 
restricted to hematopoietic and endothelial compart-
ments. In liver, the express i o n   a p p e a r e d   t o   b e   i n   t h e  
K u p f f e r   c e l l s .   I n   b o n e   m a r r o w ,   ERG  MAb  did  not 
show  reactivity  with  megakaryocytes.  Interestingly, Journal of Cancer 2010, 1 
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eosinophils, with a characteristic ring shaped or seg-
mented/multilobed  nuclei  stained  the  nuclei  with 
ERG  MAb.  Eosinophils  are  derived  from  hemato-
poietic stem cells initially committed to the myeloid 
line and then to the basophil-eosinophil granulocyte 
l i n e a g e .   T h e   p r e s e n c e   o f   E r g   i n   t h e s e   c e l l s   s u g g e s t   i t s  
potential function in either differentiation or main-
tenance of differentiation state. During development, 
Fli1 is preferentially expressed in hematopoietic cells, 
endothelial  cells  and  in  the  mesenchyme  which  is 
m a i n l y   d e r i v e d   f r o m   n e u r a l   c r e s t   c e l l s   [29]. Similar to 
earlier  observations  [11]  we  also  observe  the 
co-expression of the Erg and Fli1 genes in both endo-
thelial and mesodermal tissues, including urogenital 
tract and precartilaginous areas. Similar  to Erg,  Fli1 
expression  also  appeared  transient  during  mouse 
e m b r y o g e n e s i s .   T h i s   r e s u l t   i s   c o n s i s t e n t   w i t h   s u b t l e  
temporal  regulation.  Whether  this  spatiotemporal 
overlap  determines  redundant  functions  or  not  re-
m a i n s   t o   b e   d e t e r m i n e d .   D u e   t o   s p e c i f i c i t y   a n d   c l a r i t y  
o f   E r g   d e t e c t i o n   i n   d e v e l o p i n g   a n d   a d u l t   m o u s e   t i s-
sues,  these  findings  will  be  valuable  in  further  as-
s e s s i n g   i n   v i v o   f u n c t i o n s   o f   E r g   i n   n o r m a l   a n d   m a-
lignant tissues. 
 
 
 
 
 
 
Figure 6. Expression pattern of Erg protein during mouse embryogenesis (E14.5): (A) Sagittal section of an E14.5 embryo 
showing a specific staining in cartillage primordium (cp) of the nasal septum (ns) similar to E12.5d. Higher magnification of 
midbrain showing capillaries staining of Erg. (C) Higher magnification of ventricle (vt) region of the heart showing strong 
ractivity in the endothelial cells (ec) along the trabeculated endocordium. (D) Higher magnification of developing lungs 
shows lack of expression in the epithelial cells of segmental bronchus (sb). Stroma with enrihed capillaires exhibit strong 
staining. (E). Higher magnification of adrenal gland with endothelial cell specific Erg staining. Journal of Cancer 2010, 1 
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Figure  7. Expression pattern of Erg protein during mouse embryogenesis(E17.5): (A) Ventricle showing trebeculated 
endocordium with endothelial specific staining of Erg. (B). High magnification of lung showing capillaries and blood vessel 
specific Erg reactivity. Note t h e   l a c k   o f   s t a i n i n g   i n   t h e   l u n g   e p i t h e l i a l .   ( C )   H i g h   m a g n i f i c a t i o n   o f   l i v e r   s h o w i n g   a   s p e c i f i c   s t a i n i n g  
is non-hepatocytes in addition to endothelial cells. (D) High magnification of adrenal gland showing random Erg in both 
cortex and medullary region consistent with fenestrated vessels. Similarly, kidney (E) and intestine (F) show endothelial 
specific staining, Open arrows show the lack of expression in the bronchial epithelial cells (B), kidney tubules (E) and in-
testinal epithelial cells in the cripte (F). Blood vessel (bv), bronchial epithelium (be). 
 
 
 
 
 
 
Figure  8.  Expression  of  Erg  protein  in  developing  liver  (E17.5).  (A)  Detection  of  Erg  protein  in  endothelial  and 
non-paranchymal cells by ERG MAb. The arrows point to megakaryocytes that lack the expression of Erg protein. (B). Erg 
staining with rabbit monoclonal ERG antibodies Epitomics EPR 3864 show endothelial and non-paranchymal cells staining. 
Megakaryocytes know to have expression of Fli1 also are detected with EPR 3864. Similar megakaryocyte specific expres-
sion is also observed with EPR 3863 and FLI1 antibodies (data not shown).  Journal of Cancer 2010, 1 
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Figure 9.   E x p r e s s i o n   o f   E r g   p r o t e i n   i n   a d u l t   t i s s u e s :   ( A )   B o n e   m a r r o w   ( B )   L i v e r  ( C   )   L u n g   ( D )   P a n c r e a s   ( E )   L y m p h a t i c   v e s s e l s  
(F) Spleen (G) Kidney (Glomeruli) (H) Thymus (I) Anterior prostate (J) Dorsal prostate (K) Lateral prostate (L) Ventral 
p r o s t a t e .   E x p r e s s i o n   i s   s e e n   m a i n l y   i n   t h e   e n d o t h e l i a l   c e l l s   i n   b l o o d   v e s s e l s   a n d   c a p i l l a r i e s   ( a r r o w s ) .   I n   b o n e   m a r r o w ,  me-
gakaryocyte show lack of Erg expression (open arrow). 
 
Materials and Methods 
Antibodies:  Recently,  we  have  reported  the 
generation and characterization of mouse monoclonal 
antibodies to ERG, showing higher specificity [24]. In 
this  study,  we  have  used  mouse  monoclonal  ERG 
antibodies along with the other commercially availa-
ble  ERG  antibodies,  a  rabbit  anti-ERG  monoclonal 
antibody  clone  EPR  3864  (Cat  No.  2805-1) [26]  and 
clone EPR 3863 (Cat No. 2849-1 )   o b t a i n e d   f r o m   E p i-
t o m i c s ,   B u r l i n g a m e ,   C A   a n d   F L I -1 a n t i b o d i e s   f r o m   D r .  
Denis  Watson,  University  of  South  Carolina,  Char-
leston, SC. Anti-GAPDH  (sc-25778, Santa Cruz Bio-
technology,  Santa  Cruz,  CA)  sheep  anti-mouse 
IgG-HRP  (NXA931,  GE  Health  Care,  Buckingham-
shire, UK) donkey anti-rabbit  IgG-HRP  (NA934,  GE 
Health Care, Buckinghamshire, UK) 
Western blot assays. Cells (Jurkat, MCF7, KG1, 
M o l t 4 ,   V C a P ,   L N C a P )   w e r e   l y s e d   i n   M a m m a l i a n  
Protein  Extraction  Reagent  (M-PER)  (Pierce,  Rock-
ford,  IL)  containing  protease  inhibitor  cocktail  and 
phosphatase inhibitor cocktails I & II (Sigma, St Louis, 
MO). C e l l   l y s a t e s   e q u i v a l e n t   t o   5 0   μ g   o f   p r o t e i n   w e r e  
separated on 4-1 2 %   B i s -Tris Gel (Invitrogen, Carlsbad, 
CA) and transferred to PVDF membrane (Invitrogen, 
C a r l s b a d ,   C A ) .   M e m b r a n e s   w e r e   i n c u b a t e d   w i t h   p r i-
mary  antibodies:  Anti-ERG mouse  monoclonal  anti-
body (ERG  MAb)[24] (1:500 dilution), rabbit monoc-
lonal ERG (EPR 3864 and EPR 3863) antibodies (1:500 
dilution)  anti-GAPDH  (sc-25778,  Santa  Cruz  Bio-
technology,  Santa  Cruz,  CA)  at  4°C  for  overnight. 
Membranes were washed three times for 5 minutes 
each at room temperature followed by treatment with 
secondary antibodies: sheep anti-mouse  IgG-HRP  or 
donkey  anti-rabbit  IgG-HRP at 24°C for 1 hour. Fi-
nally membranes were washed three times and bands 
were  visualized  with  ECL  Western  blot  detection 
reagent (GE Health Care, Buckinghamshire, UK).  
Immunofluorescence staining for ERG in cell 
lines  and  flow  cytometry  analysis.  The  cancer  cell 
lines used in this study were obtained from ATCC. 
VCaP  cells  were  grown  in 
DMEM/10%FCS+Penicillin/Streptomycin/L-Glutam
ine.  LNCaP, T2, Jurkat, KG-1 and KG-1a cells were Journal of Cancer 2010, 1 
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cultured  in  RPMI/10%FCS/Penicillin/ 
Streptomycin/L-Glutamine. O n   t h e   d a y   o f   t h e   a s s a y  
a d h e r e n t   c e l l   l i n e s   ( V C a P ,   L N C a P )   w e r e   t r y p s i n i z e d  
to  yield  single  cell  suspensions  while  the 
non-adherent cells (T2, Jurkat, KG-1 and KG-1a) were 
u t i l i z e d   a f t e r   a   w a s h i n g   s t e p .   F o r   e a c h   c e l l   l i n e ,   t w o  
aliquots of 5x10
5 cells/tube were permeabilized with 
freshly prepared permeabilization buffer as directed 
by the manufacturer (eBioscience). One aliquot was 
s t a i n e d   w i t h   a n   I g G 1   i s o t y p e   c o n t r o l   a n t i b o d y   ( I n v i-
trogen) and the second aliquot was stained with the 
anti-ERG antibody at a 1:20 dilution for 1 hour at 4oC. 
Then  cells  were  washed  and  stained  with 
FITC-conjugated rat anti-mouse IgG1 antibody (Clone 
A85-1, BD Pharmingen) for an additional 30 minutes 
at 4oC. Cells were then washed and analyzed by using 
a   B D   F A C S   C a n t o   I I   f l o w   cytometer. Data was col-
l e c t e d   o n   t h e   t o t a l   c e l l   p o p u l a t i o n   a n d   t h e   a n a l y s i s  
was performed by using FACS Diva software (version 
5 .03) (Becton Dickinson). 
Tissues  and  processing  for  Immuno-
histochemistry:  Fixation  and  impregnation  FVB/N 
a n d   C 5 7 B L 6   m i c e   e m b r yos  from  various  stages  of 
development were dissected from pregnant females, 
washed  in  ice-cold  phosphate-buffered saline (PBS) 
and fixed in ice-cold 4% paraformaldehyde overnight, 
sequentially dehydration, embedding, and sectioning 
steps were performed acc o r d i n g   t o   e s t a b l i s h e d   p r o-
tocols. 
Preparation for staining: Slides (with 5-mm sec-
tions) were warmed at 60oC   f o r   1 5   m i n u t e s   a n d   i m-
mediately immersed in xylene for effective removal of 
paraffin and processed additionally twice in xylene 
f o r   5   m i n   e a c h ,   w a s h e d   t w i c e   i n   1 0 0 %   e t h a n o l   f o r   5  
m i n   e a c h ,   a n d   s u b s e q u e n t l y   r e h y d r a t e d   i n   9 5 ,   7 5 %  
ethanol, and PBS for 5 min at room temperature.  
Immunohistochemistry:  Antigen  retrieval  was 
performed on these slides in Antigen unmasking so-
lution  (Vector  Biolabs,  Burlingame,  CA)  by  using 
vegetable steamer for 45 minutes and the slides were 
allowed to cool to room temperature for about 30 min. 
Slides were washed twice in 1xPBS and treated with 
3% H2O2 i n   u l t r a p u r e   w a t e r   f o r   1 5   m i n u t e s   t o   q u e n c h  
the  endogenous  peroxidase  activity.  Immunodetec-
tion was performed using Mouse–to-mouse detection 
system  kit  according  manufacturer’s  instructions 
(Millipore  Inc.  Billerica,  MA).  Briefly,  nonspecific 
binding of the antibody was blocked by incubating 
the slides with pre-blocking solution for 10 minutes at 
RT, primary antibodies (200 pg/ml in 10% normal 
goat serum) at 4oC overnight or room temperature for 
2   h o u r s .   S l i d e s   w e r e   w a s h e d   t w i c e   i n   1 x P B S   s i t e s   5  
min each, incubated with post-antibody blocking so-
lution for 10 min. Slides were washed twice in 1xPBS 
sites  5  min  each  and  incubated  with  ready-to-use 
poly-HRP-Anti-Mouse/Rabbit  I g G   f o r   3 0   m i n u t e s ,  
w a s h e d   t w i c e   w i t h   1 x P B S   f o r   5   m i n u t e s   e a c h .   C o l o r  
d e v e l o p m e n t   w a s   p e r f o r m e d   b y   u s i n g   D A B   a s   a   s u b-
strate for peroxidase enzyme activity. The color reac-
tion was stopped by washing/rinsing slides in tap 
water several times. Slides were counterstained with 
H e m a t o x y l e n e   f o r   2   m i n u t e s ,   r i n s e d   i n   t a p   w a t e r   f o r   5  
mins,  dehydrated  sequentially  in  ascending  concen-
tration of alcohol, cleared in xylene and permanently 
m o u n t e d   w i t h   P e r m o n t   s o l u t i o n .   T h e   s l i d e s   w e r e  
scanned in Biomedical Instrumentation Center at Un-
iformed  Services  University  of  the  Health  Sciences 
using Olympus NanoZoomer Digital Pathology mi-
croscope  at  40X  magnification  and  digital  images 
were taken from the scans. 
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